Recall: Metformin ER
Jan. 2022Pharmacy Updates
Viona Pharmaceuticals Inc. has recalled 33 lots of Metformin Hydrochloride Extended-Release Tablets, USP, 750 mg because an impurity found in the products is above levels established by the Food and Drug Administration. Read the full text of the Metformin ER recall.
Recent Announcements
Understanding MP.PA.147
Understanding changes to the Diagnostic and Surveillance Colonoscopy, 18 Years Old and Older – MP.PA.147 policyJul. 2025Important Notices
Understanding MP.PA.147
Understanding changes to the Diagnostic and Surveillance Colonoscopy, 18 Years Old and Older – MP.PA.147 policyJul. 2025Important Notices
Register for the Oral Health in Your Pediatric Office CME -accredited webinar
Please join us for a live, CME-accredited webinar on Wednesday, Sept. 10 from noon to 1 p.m. that will provide an overview of oral health in your pediatric office. Providers with a(n) MD/DO, PA, CRNP, RN, or LPN may also apply for topical fluoride certification after completion of this course.Jun. 2025Education/Webinars